Ellevest Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
792
+19
| +2% | +$6.2K | 0.04% | 329 |
|
|
2025
Q1 | $209K | Sell |
773
-651
| -46% | -$176K | 0.01% | 367 |
|
|
2024
Q4 | $335K | Sell |
1,424
-450
| -24% | -$106K | 0.02% | 286 |
|
|
2024
Q3 | $515K | Buy |
+1,874
| New | +$515K | 0.03% | 208 |
|
|
2024
Q1 | – | Sell |
-1,348
| Closed | -$258K | – | 403 |
|
|
2023
Q4 | $258K | Sell |
1,348
-68
| -5% | -$13K | 0.02% | 324 |
|
|
2023
Q3 | $251K | Buy |
1,416
+56
| +4% | +$9.92K | 0.02% | 294 |
|
|
2023
Q2 | $258K | Buy |
1,360
+491
| +57% | +$93.3K | 0.02% | 294 |
|
|
2023
Q1 | $174K | Sell |
869
-230
| -21% | -$46.1K | 0.01% | 341 |
|
|
2022
Q4 | $261K | Buy |
1,099
+11
| +1% | +$2.61K | 0.02% | 256 |
|
|
2022
Q3 | $218K | Buy |
1,088
+98
| +10% | +$19.6K | 0.02% | 258 |
|
|
2022
Q2 | $144K | Buy |
990
+198
| +25% | +$28.8K | 0.01% | 344 |
|
|
2022
Q1 | $129K | Sell |
792
-153
| -16% | -$24.9K | 0.01% | 370 |
|
|
2021
Q4 | $160K | Sell |
945
-126
| -12% | -$21.3K | 0.01% | 320 |
|
|
2021
Q3 | $202K | Buy |
1,071
+62
| +6% | +$11.7K | 0.02% | 274 |
|
|
2021
Q2 | $171K | Buy |
1,009
+94
| +10% | +$15.9K | 0.02% | 289 |
|
|
2021
Q1 | $129K | Buy |
915
+220
| +32% | +$31K | 0.02% | 303 |
|
|
2020
Q4 | $90K | Buy |
695
+135
| +24% | +$17.5K | 0.01% | 330 |
|
|
2020
Q3 | $82K | Buy |
560
+554
| +9,233% | +$81.1K | 0.01% | 303 |
|
|
2020
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 947 |
|